QLTI Related Corporate News

Apr 15, 2013 07:37 AM QLT, Inc. (QLTI) Board Approves $200M Special Cash Distribution, or $3.95/Sh

Dec 24, 2012 08:03 AM QLT Inc. QLTI) Grants Purchase Option for PPDS Unit

Dec 6, 2012 08:06 AM QLT Inc. (QLTI) to Cut Workforce by 42%

Sep 24, 2012 07:32 AM QLT (QLTI) Completes $112.5M Sale of Visudyne to Valeant (VRX)

Jul 9, 2012 07:10 AM QLT Inc. (QLTI) Chairman Aryeh Updates on Corp. Strategy; CEO Butchofsky to Leave, Will Trim Jobs

May 24, 2012 04:29 PM QLT Inc. (QLTI) Announces Board Will Propose $75-$100M Dutch Auction Tender Offer

May 23, 2012 08:57 AM QLT Inc. (QLTI) Issues Response to Nordic Biotech Notification on Board Nominees

May 23, 2012 08:56 AM QLT Inc. (QLTI) Says Nordic Biotech to Vote 7.4M Common in Favor of Nominees

Sep 14, 2011 06:31 AM QLT (QLTI) Gets Fast Track from FDA for QLT091001 as LCA Treatment

Aug 29, 2011 06:31 AM QLT Inc. (QLTI) Reports Statistically Significant Data from L-PPDS Phase 2

May 3, 2011 06:38 AM QLT Inc. (QLTI) Reports Positive QLT091001 Phase 1b Results

Feb 10, 2011 07:11 AM QLT (QLTI) Receives Positive Orphan Drug Opinions In Europe

Feb 9, 2011 07:21 AM QLT (QLTI) Updates on O-PPDS Phase II

Dec 10, 2010 06:52 AM Toronto Stock Exchange Accepts QLT, Inc.'s (QLTI) Stock Repurchase Program

Dec 7, 2010 04:06 PM QLT Inc. (QLTI) Announces QLT091001 Granted Orphan Drug Designation by the U.S. FDA

Jun 28, 2010 06:47 AM QLT (QLTI) Added to Russell Global Index

Jun 22, 2010 07:00 AM QLT (QLTI) Announces Results from Phase II RADICAL in Patients with Wet AMD; Fewer Retreatments Needed

Jun 15, 2010 04:06 PM QLT Inc. (QLTI) Issues 12-Month Results from DENALI Study on verteporfin PDT; Trial Didn't Show Non-Inferior Gain

Jun 15, 2010 04:00 PM QLT Inc. (QLTI) trading halted with news pending

Apr 20, 2010 07:58 AM QLT (QLTI) Announces Positive Data from QLT091001 LCA Treatment Phase 1b in Three Patients

Dec 30, 2009 04:32 PM QLT Inc. (QLTI) Acquires OT-730 Beta Blocker from Othera Pharmaceuticals

Nov 25, 2009 07:08 AM QLT (QLTI) Settles Litigation with General Hospital of Massachusetts

Oct 19, 2009 07:03 AM QLT Inc. (QLTI) Announces Simplified Novartis Pharma (NVS) Relationship; Will Have Exclusive Visudyne Rights

Oct 1, 2009 05:12 PM QLT Inc. (QLTI) Completes Sale of QLT USA to TOLMAR for Up to $230M

Sep 8, 2009 08:07 AM QLT (QLTI) Announces $45.3M Tax Refund In Canada

May 22, 2009 07:48 AM Massachusetts Court Dismisses All Claims Filed by MGH Against QLT Inc. (QLTI) Except Those Under Chapter 93A

Jan 12, 2009 04:33 PM QLT Inc. (QLTI) Reports Visudyne(R) Sales for Q4, FY08

Mar 28, 2008 11:37 AM QLT (QLTI) Announces Positive Results from Visudyne(R)

Jan 18, 2008 08:40 AM QLT (QLTI) To Reduce Workforce

Jan 17, 2008 07:45 AM QLT (QLTI) Reports Visudyne(R) Sales for 2007

Jul 10, 2007 03:14 PM QLT Inc. (QLTI) Says District Court of Massachusetts Upholds Decision in Favor of Massachusetts Eye and Ear Infirmary

Feb 9, 2007 02:24 PM QLT (QLTI) In Agreement with TAP to Settle US Patent Litigation

Mar 6, 2006 11:46 PM QLTI Updates Eligard Patent Litigation